People

Adam Pelavin

sec.gov

Adam Pelavin is a LifeForce Capital partner, promoted in June2023 after serving as adviser and venture partner from June2016. Orgenesis’2026 issuer filing says he co-leads LifeForce’s AI-plus-health and neuroscience strategies, investing in software-driven drug development and care delivery. Earlier he co-founded Comprisma to address healthcare financial incentives, worked in education policy and research, and earned a mathematics degree from Pomona College and an MFA in fiction from the University of California Riverside. Orgenesis publishes his named director portrait; the corporate board affiliation is evidence for his biography, not an inferred personal cash investment.